Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Authors: Shomuradova et al.

Link to paper:

Journal/ Pre-Print: medRxiv

Key Words: Immunology

Research Highlights

1. SARS-CoV-2-specific T cells are increased in healthy donors examined during COVID-19 suggesting that some individuals might be protected by T-cell cross-reactivity

2. In convalescent patients both a public and diverse T-cell response to SARS-CoV-2 epitopes were observed, revealing T-cell receptor motifs with germline-encoded features

3. Bulk T-cell responses to Spike (S) glycoprotein were mediated by groups of homologous T-cell receptors, of which some are shared between multiple donors


Antibody and T-cell reactivity was analysed in 31 COVID-19 convalescent patients (CP), compared to healthy donors (HD) sampled prior to (20) or during (14) the pandemic. All bar two CPs had IgG specific to SARS-CoV-2 antigens. T-cell responses to S-protein were highly variable with some CPs lacking response. All CPs exhibited T-cell reactivity to at least one SARS CoV-2 protein. CPs can be discriminated from HDs by response to two HLA-A*02:01-restricted SARS-CoV-2 S-protein epitopes. High-throughput TCR sequencing of FACS-sorted IFNg-secreting T cells showed that TCRs specific to the two SARS-CoV-2 epitopes are characterized by diverse public motifs.

Impact for SARS-CoV2/COVID19 research efforts

Understand the immune response to SARS-CoV2/COVID19

Study Type

· In vitro study

Strengths and limitations of the paper

Novelty: Confirms some previous findings in terms of T-cell reactivity against SARS-CoV-2 but profiles the TCR repertoire more thoroughly

Standing in the field: Many of their findings appear to be consistent with previous reports while some do not support previous findings (e.g. no correlation between anti-SARS-CoV-2 antibody titres and patient age)

Appropriate statistics: Yes. For Figure 2a and 2b it would have been useful to be able to see the variation

Viral model used: PBMCs of COVID-19-confirmed patients and healthy donors

Translatability: The finding that the immune response to two HLA-A*02:01-restricted SARS-CoV-2 S-protein epitopes distinguishes convalescent from healthy donors could potentially be useful for vaccine development. The presence of SARS-CoV-2 specific IgG antibodies in convalescent patients and their complete absence in healthy donors confirms the utility of this assay to identify individuals previously exposed to the virus.

Main limitations: The authors use IFNg-secretion upon stimulation as a readout of antigen-specific cells, which might miss some relevant T cells. Also, none of the CPs had severe disease (requiring ICU admission)